Novartis' Indian patent fight continues in court; Cipla eyes supply deal with Planned Parenthood;

 @FiercePharma: WSJ's story on the Chinese drug-price cuts: Report | Follow @FiercePharma

> Final hearings have begun before India's Supreme Court in Novartis' ($NVS) fight for a patent on its cancer drug Glivec. Report

> India's Cipla, targeting expansion of its contraceptive franchise, is in talks with International Planned Parenthood about supplying its birth control pills to developing countries. Report

> A Finnish drugmaker supplied medicines to the country's ski team, in violation of anti-doping rules, but the arrangement ended in 1998 and the company won't be prosecuted. Report

> Jazz Pharmaceuticals' stock leapt 14% on a judge's ruling in favor of the patent on its narcolepsy drug Xyrem. Report

> Sunovion Pharmaceuticals launched its antipsychotic drug Latuda in Canada. Report

> Pfizer ($PFE) published a guide for safe disposal of medicines aimed at healthcare providers. Report

Medical Device News

 @FierceMedDev: BioFire Diagnostics pulls in $25M in new funding for accelerated product development. Release | Follow @FierceMedDev

 @MarkHFierce: The iPhone 5 could accelerate the migration of medical devices to Bluetooth, eWeek reports. More | Follow @MarkHFierce

 @DamianFierce: Medtronic is looking to pair its pump technology with the next generation of Alzheimer's drugs. Report | Follow @DamianFierce

> J&J plans innovation centers, looking for buys and team-ups. Story

> Navidea launches PhII for Alzheimer's imaging. News

Biotech News

 @FierceBiotech: Bedside blood infection test being developed for sepsis. Item | Follow @FierceBiotech

 @JohnCFierce: Interesting: J&J setting up 4 deal teams around the globe - Boston. California. China and London. Via Reuters: Report | Follow @JohnCFierce

 @RyanMFierce: Fierce 15 arrives tomorrow. Here are some details on what to expect: More | Follow @RyanMFierce

> Medtronic dangles Alzheimer's delivery tech to frustrated pharmas. Story

> Software mogul commits $104M to CureVac's cancer vax work. More

Pharma Manufacturing News

> Gelatin prices look to rise steeply. Story

> Boehringer Ingelheim closing 1 of 3 U.S. API plants. More

> India says it will meet EU's API quality deadline. Report

Biotech Research News

> Mayo Clinic spies enzyme that destroys brain-clogging Alzheimer's protein. More

> Drug combo packs punch fighting rare form of melanoma in mice. Story

> UMass sensor array 'smelled' metastatic cancer cells in preclinical study. Article

And Finally ... FDA slapped Lancôme for claims made about its anti-aging creams. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.